Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye Syndrome [NA]

View source ↗

Summary

Clinical trial evaluated safety and effectiveness of an intranasal lacrimal neurostimulator for dry eye syndrome; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome
• Keratoconjunctivitis Sicca

Drugs mentioned

• Oculeve Intranasal Lacrimal Neurostimulator

Snippet

Sponsor: Oculeve, Inc. | Conditions: Dry Eye Syndrome, Keratoconjunctivitis Sicca | NA | Status: COMPLETED | Results posted: 2019-04-26